Browse drugs

…is limitation, we evaluated the efficacy and safety of combined ipilimumab and nivolumab (IPI/NIVO) with subablative radiotherapy (RT) in …

…re similarly observed with another immune checkpoint inhibitor, anti-TIM-3, broadening this mechanism as a major one during checkpoint blo…

…to a diagnosis of thyroid storm. Given his prior treatment with nivolumab and ipilimumab, destructive thyroiditis was initially suspected…

…mic bone marrow metastasis that achieved a complete response to ipilimumab plus nivolumab. Using matched pretreatment and post-treatment b…

…esectable CSCC. Neoadjuvant ICIs studies, including cemiplimab, pembrolizumab, and nivolumab±ipilimumab, have reported consistent and strikin…

…n elderly woman with metastatic malignant melanoma treated with nivolumab, a programmed cell death protein 1 immune checkpoint inhibitor.…

…Background Nivolumab plus ipilimumab (COMBO) is the standard treatment for asymptoma…

…cts. We describe a complex case of NT1 following ipilimumab and nivolumab exposure for management of metastatic melanoma.…

…static non-small cell lung cancer, occurring after 36 cycles of nivolumab therapy. A bone marrow aspirate was performed which showed myel…

…ere maintenance FMT (10 capsules per treatment) was paired with nivolumab at 3 mg/kg every 2 weeks for six cycles. Serial biomarker asses…

…gimens for rNSCLC were durvalumab, nivolumab, pembrolizumab and toripalimab. The estimated hazard ratio of immunotherapy regimens for the a…

…ucted, including all patients who received at least one dose of pembrolizumab, nivolumab, or atezolizumab as first-line treatment for metasta…